Recurrent infection with Pseudomonas aeruginosa during eculizumab therapy in an allogeneic hematopoietic stem cell transplant recipient

Webb B. J.; Healy R.; Child B.; Majers J.; Anand S.; Gouw L.

首页> 外文期刊>Transplant infectious disease: an official journal of the Transplantation Society >Recurrent infection with Pseudomonas aeruginosa during eculizumab therapy in an allogeneic hematopoietic stem cell transplant recipient

【24h】

Recurrent infection with Pseudomonas aeruginosa during eculizumab therapy in an allogeneic hematopoietic stem cell transplant recipient

机译：异基因造血干细胞移植受者接受依库丽单抗治疗期间铜绿假单胞菌的反复感染

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transplant infectious disease: an official journal of the Transplantation Society》 |2016年第2期|共3页
作者
Webb B. J.; Healy R.; Child B.; Majers J.; Anand S.; Gouw L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
Pseudomonas aeruginosa; eculizumab; complement; hematopoietic stem cell transplant;

机译：铜绿假单胞菌;依库丽单抗;补体;造血干细胞移植;

相似文献

外文文献
中文文献
专利

1. Recurrent infection with Pseudomonas aeruginosa during eculizumab therapy in an allogeneic hematopoietic stem cell transplant recipient [J] . Webb B. J., Healy R., Child B., Transplant infectious disease: an official journal of the Transplantation Society . 2016,第2期

机译：异基因造血干细胞移植受者接受依库丽单抗治疗期间铜绿假单胞菌的反复感染
2. Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients [J] . Flaminia Olearo, Ilona Kronig, Stavroula Masouridi-Levrat, Open Forum Infectious Diseases . 2020,第7期

机译：异种造血细胞移植受者的铜绿假单胞菌铜绿假单胞菌感染的最佳治疗持续时间
3. Control of Multidrug-Resistant Pseudomonas aeruginosa in Allogeneic Hematopoietic Stem Cell Transplant Recipients by a Novel Bundle Including Remodeling of Sanitary and Water Supply Systems (vol 65, pg 935, 2017) [J] . Kossow A., Kampmeier S., Willems S. Clinical infectious diseases . 2019,第3期

机译：通过一种新颖的捆绑控制同种异体造血干细胞移植受体中的多药抗性假单胞菌铜绿假单胞菌，包括改造卫生和供水系统（Vol 65，PG 935,2017）
4. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS [C] . Sousuke Nakamura International Molecular Medicine Tri-Conference. . 2019

机译：循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
5. The burden of parainfluenza virus infection in patients with hematological malignancy and hematopoietic stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of infection control. [D] . Hanmod, Santosh S. 2009

机译：在没有积极免疫和批准治疗的情况下，血液恶性肿瘤和造血干细胞移植（HSCT）患者的副流感病毒感染负担：感染控制的作用。
6. Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients [O] . Flaminia Olearo, Ilona Kronig, Stavroula Masouridi-Levrat, 2020

机译：异基因造血细胞移植受者中铜绿假单胞菌感染的最佳治疗持续时间
7. Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients [O] . Flaminia Olearo, Ilona Kronig, Stavroula Masouridi-Levrat, 2020

机译：异种造血细胞移植受者的铜绿假单胞菌铜绿假单胞菌感染的最佳治疗持续时间

Recurrent infection with Pseudomonas aeruginosa during eculizumab therapy in an allogeneic hematopoietic stem cell transplant recipient

著录项

相似文献

相关主题

期刊订阅